{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T09:42:49Z","timestamp":1790674969943,"version":"4.1.0"},"reference-count":69,"publisher":"Oxford University Press (OUP)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,7,15]]},"DOI":"10.1093\/cid\/cis382","type":"journal-article","created":{"date-parts":[[2012,4,5]],"date-time":"2012-04-05T00:22:05Z","timestamp":1333585325000},"page":"279-290","source":"Crossref","is-referenced-by-count":51,"title":["Cost-effective Screening for Acute Hepatitis C Virus Infection in HIV-Infected Men Who Have Sex With Men"],"prefix":"10.1093","volume":"55","author":[{"given":"Benjamin P.","family":"Linas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela Y.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce R.","family":"Schackman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur Y.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth A.","family":"Freedberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2012,4,4]]},"reference":[{"key":"key\n\t\t\t\t20170522105241_CIS382C1","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1136\/sti.2006.021493","article-title":"Increase in hepatitis C virus incidence in HIV-1-infected patients followed up since primary infection","volume":"82","author":"Ghosn","year":"2006","journal-title":"Sex Transm Infect"},{"key":"key\n\t\t\t\t20170522105241_CIS382C2","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1097\/QAD.0b013e3281053a0c","article-title":"Recent epidemic of acute hepatitis C virus in HIV-positive men who have sex with men linked to high-risk sexual behaviours","volume":"21","author":"Danta","year":"2007","journal-title":"AIDS"},{"key":"key\n\t\t\t\t20170522105241_CIS382C3","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1136\/sti.2003.008532","article-title":"Increased numbers of acute hepatitis C infections in HIV positive homosexual men; is sexual transmission feeding the increase?","volume":"80","author":"Browne","year":"2004","journal-title":"Sex Transm Infect"},{"key":"key\n\t\t\t\t20170522105241_CIS382C4","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1097\/01.aids.0000171412.61360.f8","article-title":"A cluster of acute hepatitis C virus infection among men who have sex with men\u2014results from contact tracing and public health implications","volume":"19","author":"Gotz","year":"2005","journal-title":"AIDS"},{"key":"key\n\t\t\t\t20170522105241_CIS382C5","doi-asserted-by":"crossref","first-page":"115","DOI":"10.2807\/esm.10.05.00535-en","article-title":"Acute hepatitis C infection in HIV positive men who have sex with men in Paris, France, 2001\u20132004","volume":"10","author":"Gambotti","year":"2005","journal-title":"Euro Surveill"},{"key":"key\n\t\t\t\t20170522105241_CIS382C6","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1086\/518796","article-title":"Increase in HCV incidence among men who have sex with men in Amsterdam most likely caused by sexual transmission","volume":"196","author":"van de Laar","year":"2007","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20170522105241_CIS382C7","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/01.aids.0000200541.40633.56","article-title":"Sexually transmitted acute infection with a clustered genotype 4 hepatitis C virus in HIV-1-infected men and inefficacy of early antiviral therapy","volume":"20","author":"Serpaggi","year":"2006","journal-title":"AIDS"},{"key":"key\n\t\t\t\t20170522105241_CIS382C8","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1086\/590430","article-title":"Liver fibrosis during an outbreak of acute hepatitis C virus infection in HIV-infected men: a prospective cohort study","volume":"198","author":"Fierer","year":"2008","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20170522105241_CIS382C9","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/01.qai.0000191281.77954.27","article-title":"Clinical presentation and course of acute hepatitis C infection in HIV-infected patients","volume":"41","author":"Luetkemeyer","year":"2006","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key\n\t\t\t\t20170522105241_CIS382C10","doi-asserted-by":"crossref","first-page":"19673","DOI":"10.2807\/ese.15.39.19673-en","article-title":"Hepatitis C virus infection in HIV-infected men who have sex with men: sustained rising incidence in Antwerp, Belgium, 2001\u20132009","volume":"15","author":"Bottieau","year":"2010","journal-title":"Euro Surveill"},{"key":"key\n\t\t\t\t20170522105241_CIS382C11","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1093\/cid\/ciq201","article-title":"Incident hepatitis C virus infection among US HIV-infected men enrolled in clinical trials","volume":"52","author":"Taylor","year":"2011","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170522105241_CIS382C12","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1086\/431486","article-title":"Unsafe sex and increased incidence of hepatitis C virus infection among HIV-infected men who have sex with men: the Swiss HIV Cohort Study","volume":"41","author":"Rauch","year":"2005","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170522105241_CIS382C13","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1471-2334-11-39","article-title":"Incidence of hepatitis-C among HIV infected men who have sex with men (MSM) attending a sexual health service: a cohort study","volume":"11","author":"Gamage","year":"2011","journal-title":"BMC Infect Dis"},{"key":"key\n\t\t\t\t20170522105241_CIS382C14","first-page":"613","article-title":"Effects of hepatitis C virus coinfection on survival in veterans with HIV treated with highly active antiretroviral therapy","volume":"39","author":"Backus","year":"2005","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key\n\t\t\t\t20170522105241_CIS382C15","first-page":"945","article-title":"Sexual transmission of hepatitis C virus among HIV-infected men who have sex with men \u2013- New York City, 2005\u20132010","volume":"60","year":"2011","journal-title":"MMWR Morbidity and Mortality Weekly Report"},{"key":"key\n\t\t\t\t20170522105241_CIS382C16","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1097\/QAD.0b013e32833c11a5","article-title":"Acute hepatitis C in HIV-infected men who have sex with men: an emerging sexually transmitted infection","volume":"24","author":"van de Laar","year":"2010","journal-title":"AIDS"},{"key":"key\n\t\t\t\t20170522105241_CIS382C17","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/QAD.0b013e328343443b","article-title":"Acute hepatitis C in HIV-infected individuals: recommendations from the European AIDS Treatment Network (NEAT) consensus conference","volume":"25","year":"2011","journal-title":"AIDS"},{"key":"key\n\t\t\t\t20170522105241_CIS382C18","first-page":"1","article-title":"Sexually transmitted diseases treatment guidelines, 2010","volume":"59","author":"Workowski","year":"2010","journal-title":"MMWR Recomm Rep"},{"key":"key\n\t\t\t\t20170522105241_CIS382C19","doi-asserted-by":"crossref","first-page":"465","DOI":"10.7326\/0003-4819-140-6-200403160-00014","article-title":"Screening for hepatitis C virus infection: a review of the evidence for the U.S. Preventive Services Task Force","volume":"140","author":"Chou","year":"2004","journal-title":"Ann Intern Med"},{"key":"key\n\t\t\t\t20170522105241_CIS382C20","doi-asserted-by":"crossref","DOI":"10.1093\/oso\/9780195108248.001.0001","volume-title":"Cost effectiveness in health and medicine","author":"Gold","year":"1996"},{"key":"key\n\t\t\t\t20170522105241_CIS382C21","volume-title":"Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents","author":"Panel on Antiretroviral Guidelines for Adults and Adolescents"},{"key":"key\n\t\t\t\t20170522105241_CIS382C22","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1046\/j.1524-4733.2003.00234.x","article-title":"Principles of good practice for decision analytic modeling in health-care evaluation: report of the ISPOR Task Force on Good Research Practices\u2013Modeling Studies","volume":"6","author":"Weinstein","year":"2003","journal-title":"Value Health"},{"key":"key\n\t\t\t\t20170522105241_CIS382C23","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1086\/652650","article-title":"Late presentation for human immunodeficiency virus care in the United States and Canada","volume":"50","author":"Althoff","year":"2010","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170522105241_CIS382C24","doi-asserted-by":"crossref","first-page":"6689","DOI":"10.3748\/wjg.14.6689","article-title":"Co-infection of hepatitis B and hepatitis C virus in human immunodeficiency virus-infected patients in New York City, United States","volume":"14","author":"Kim","year":"2008","journal-title":"World J Gastroenterol"},{"key":"key\n\t\t\t\t20170522105241_CIS382C25","doi-asserted-by":"crossref","first-page":"F21","DOI":"10.1097\/QAD.0b013e32834bac44","article-title":"Alarming incidence of hepatitis C virus re-infection after treatment of sexually acquired acute hepatitis C virus infection in HIV-infected MSM","volume":"25","author":"Lambers","year":"2011","journal-title":"AIDS"},{"key":"key\n\t\t\t\t20170522105241_CIS382C26","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1128\/JCM.36.4.862-865.1998","article-title":"Multicenter evaluation of the COBAS AMPLICOR HCV assay, an integrated PCR system for rapid detection of hepatitis C virus RNA in the diagnostic laboratory","volume":"36","author":"Albadalejo","year":"1998","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t20170522105241_CIS382C27","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/QAD.0b013e32831940a3","article-title":"Delayed anti-HCV antibody response in HIV-positive men acutely infected with HCV","volume":"23","author":"Thomson","year":"2009","journal-title":"AIDS"},{"key":"key\n\t\t\t\t20170522105241_CIS382C28","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.jviromet.2009.08.008","article-title":"Evaluation of the performance of the EIAgen HCV test for detection of hepatitis C virus infection","volume":"162","author":"Rao","year":"2009","journal-title":"J Virol Methods"},{"key":"key\n\t\t\t\t20170522105241_CIS382C29","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1365-2893.2006.00783.x","article-title":"Comparative study between occult hepatitis C virus infection and chronic hepatitis C","volume":"14","author":"Pardo","year":"2007","journal-title":"J Viral Hepat"},{"key":"key\n\t\t\t\t20170522105241_CIS382C30","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1097\/QAI.0b013e318198a88a","article-title":"Nonalcoholic fatty liver disease among HIV-infected persons","volume":"50","author":"Crum-Cianflone","year":"2009","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key\n\t\t\t\t20170522105241_CIS382C31","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S0749-3797(03)00115-6","article-title":"Cost comparison of three HIV counseling and testing technologies","volume":"25","author":"Ekwueme","year":"2003","journal-title":"Am J Prev Med"},{"key":"key\n\t\t\t\t20170522105241_CIS382C32","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1097\/QAD.0b013e328330ed24","article-title":"Acute hepatitis C in HIV-infected patients: rare spontaneous clearance correlates with weak memory CD4 T-cell responses to hepatitis C virus","volume":"23","author":"Schnuriger","year":"2009","journal-title":"AIDS"},{"key":"key\n\t\t\t\t20170522105241_CIS382C33","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1177\/135965350701200605","article-title":"Natural history of compensated and decompensated HCV-related cirrhosis in HIV-infected patients: a prospective multicentre study","volume":"12","author":"Giron-Gonzalez","year":"2007","journal-title":"Antivir Ther"},{"key":"key\n\t\t\t\t20170522105241_CIS382C34","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1111\/j.1365-2893.2010.01325.x","article-title":"The impact of HIV\/HCV co-infection on healthcare utilization and disability: results of the ACTG Longitudinal Linked Randomized Trials (ALLRT) Cohort","volume":"18","author":"Linas","year":"2011","journal-title":"J Viral Hepat"},{"key":"key\n\t\t\t\t20170522105241_CIS382C35","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1111\/j.1572-0241.2003.07332.x","article-title":"Health-state utilities and quality of life in hepatitis C patients","volume":"98","author":"Chong","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"key\n\t\t\t\t20170522105241_CIS382C36","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1136\/gut.2005.064774","article-title":"Cost effectiveness of interferon alpha or peginterferon alpha with ribavirin for histologically mild chronic hepatitis C","volume":"55","author":"Grieve","year":"2006","journal-title":"Gut"},{"key":"key\n\t\t\t\t20170522105241_CIS382C37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta6310","article-title":"Screening for hepatitis C among injecting drug users and in genitourinary medicine clinics: systematic reviews of effectiveness, modelling study and national survey of current practice","volume":"6","author":"Stein","year":"2002","journal-title":"Health Technol Assess"},{"key":"key\n\t\t\t\t20170522105241_CIS382C38","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1086\/605676","article-title":"Natural history of compensated hepatitis C virus-related cirrhosis in HIV-infected patients","volume":"49","author":"Pineda","year":"2009","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170522105241_CIS382C39","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/hep.23020","article-title":"Sustained virological response to interferon plus ribavirin reduces liver-related complications and mortality in patients coinfected with human immunodeficiency virus and hepatitis C virus","volume":"50","author":"Berenguer","year":"2009","journal-title":"Hepatology"},{"key":"key\n\t\t\t\t20170522105241_CIS382C40","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1086\/596770","article-title":"Characteristics and treatment outcomes among HIV-infected individuals in the Australian Trial in Acute Hepatitis C","volume":"48","author":"Matthews","year":"2009","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170522105241_CIS382C41","first-page":"CD004888","article-title":"Antiviral treatment for chronic hepatitis C in patients with human immunodeficiency virus","volume":"1","author":"Iorio","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"issue":"Suppl 5","key":"key\n\t\t\t\t20170522105241_CIS382C42","doi-asserted-by":"crossref","first-page":"S325","DOI":"10.1086\/427448","article-title":"Treatment for hepatitis C virus infection among current injection drug users in Australia","volume":"40","author":"Matthews","year":"2005","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170522105241_CIS382C43","article-title":"Interim analysis of a phase 2a double-blind study of teleprevir in combination with pegylated int4erferon alpha-2a and ribavirin in HIV\/HCV co-infected patients [abstract 146LB]","author":"Sulkowski","year":"2011"},{"key":"key\n\t\t\t\t20170522105241_CIS382C44","article-title":"Telaprevir combination with peginterferon alfa-2a\/ribavirin in HCV\/HIV coinfected patients: 24-week treatment interim analysis [abstract LB-8]","author":"Sherman","year":"2011"},{"key":"key\n\t\t\t\t20170522105241_CIS382C45","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1002\/hep.23959","article-title":"Treatment of acute hepatitis C in human immunodeficiency virus-infected patients: the HEPAIG study","volume":"52","author":"Piroth","year":"2010","journal-title":"Hepatology"},{"key":"key\n\t\t\t\t20170522105241_CIS382C46","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1097\/QAD.0b013e3283480144","article-title":"Treatment of acute hepatitis C virus infection in HIV-infected MSM: the effect of treatment duration","volume":"25","author":"Lambers","year":"2011","journal-title":"AIDS"},{"key":"key\n\t\t\t\t20170522105241_CIS382C47","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1056\/NEJMoa040842","article-title":"Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients","volume":"351","author":"Torriani","year":"2004","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170522105241_CIS382C48","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1056\/NEJM200103153441108","article-title":"The cost effectiveness of combination antiretroviral therapy for HIV disease","volume":"344","author":"Freedberg","year":"2001","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170522105241_CIS382C49","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1056\/NEJMsa042088","article-title":"Expanded screening for HIV in the United States\u2013an analysis of cost-effectiveness","volume":"352","author":"Paltiel","year":"2005","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170522105241_CIS382C50","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1056\/NEJMoa032653","article-title":"Peginterferon alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons","volume":"351","author":"Chung","year":"2004","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170522105241_CIS382C51","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/QAD.0b013e3282f1da99","article-title":"Undetectable hepatitis C virus RNA at week 4 as predictor of sustained virological response in HIV patients with chronic hepatitis C","volume":"22","author":"Martin-Carbonero","year":"2008","journal-title":"AIDS"},{"key":"key\n\t\t\t\t20170522105241_CIS382C52","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1001\/jama.292.23.2839","article-title":"Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trial","volume":"292","author":"Carrat","year":"2004","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20170522105241_CIS382C53","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1001\/archinte.163.14.1637","article-title":"What is the price of life and why doesn't it increase at the rate of inflation?","volume":"163","author":"Ubel","year":"2003","journal-title":"Arch Intern Med"},{"key":"key\n\t\t\t\t20170522105241_CIS382C54","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1097\/QAD.0b013e32830e6d51","article-title":"Natural history of hepatitis C virus infection in HIV-infected individuals and the impact of HIV in the era of highly active antiretroviral therapy: a meta-analysis","volume":"22","author":"Thein","year":"2008","journal-title":"AIDS"},{"key":"key\n\t\t\t\t20170522105241_CIS382C55","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1093\/cid\/cir854","article-title":"Liver fibrosis progression after acute hepatitis C virus infection in HIV-positive individuals","volume":"54","author":"Vogel","year":"2011","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170522105241_CIS382C56","doi-asserted-by":"crossref","first-page":"946","DOI":"10.7326\/0003-4819-126-12-199706150-00003","article-title":"Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection","volume":"126","author":"Mellors","year":"1997","journal-title":"Ann Intern Med"},{"key":"key\n\t\t\t\t20170522105241_CIS382C57","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1097\/QAI.0b013e3181b16d00","article-title":"Improving outcomes in state AIDS drug assistance programs","volume":"51","author":"Linas","year":"2009","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key\n\t\t\t\t20170522105241_CIS382C58","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1056\/NEJMoa051871","article-title":"Tenofovir DF, emtricitabine, and efavirenz vs. zidovudine, lamivudine, and efavirenz for HIV","volume":"354","author":"Gallant","year":"2006","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170522105241_CIS382C59","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/S0140-6736(07)60597-2","article-title":"Safety and efficacy of the HIV-1 integrase inhibitor raltegravir (MK-0518) in treatment-experienced patients with multidrug-resistant virus: a phase II randomised controlled trial","volume":"369","author":"Grinsztejn","year":"2007","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20170522105241_CIS382C60","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1097\/01.aids.0000166091.39317.99","article-title":"Atazanavir plus ritonavir or saquinavir, and lopinavir\/ritonavir in patients experiencing multiple virological failures","volume":"19","author":"Johnson","year":"2005","journal-title":"AIDS"},{"key":"key\n\t\t\t\t20170522105241_CIS382C61","article-title":"Efficacy and safety of maraviroc plus optimized background therapy in viremic ART experienced patients infected with CCR5-tropic HIV-1: 24-week results of a phase 2b\/3 study in the US and Canada [abstract 104bLB]","author":"Lalezari"},{"key":"key\n\t\t\t\t20170522105241_CIS382C62","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1097\/01.qai.0000185314.56556.c3","article-title":"Durable efficacy of enfuvirtide over 48 weeks in heavily treatment-experienced HIV-1-infected patients in the T-20 versus optimized background regimen only 1 and 2 clinical trials","volume":"40","author":"Nelson","year":"2005","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key\n\t\t\t\t20170522105241_CIS382C63","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1177\/0272989X0202200103","article-title":"Comparison of health state utilities using community and patient preference weights derived from a survey of patients with HIV\/AIDS","volume":"22","author":"Schackman","year":"2002","journal-title":"Med Decis Making"},{"key":"key\n\t\t\t\t20170522105241_CIS382C64","article-title":"US Department of Health and Human Services. 2009 Clinical Diagnostic Laboratory Fee Schedule","author":"Center for Medicare Services"},{"key":"key\n\t\t\t\t20170522105241_CIS382C65","article-title":"Budget of the United States government: historical tables fiscal year 2009. Table\u00a010.1","author":"United States Department of Management and Budget"},{"key":"key\n\t\t\t\t20170522105241_CIS382C66","volume-title":"2009 Red book: Pharmacy's fundamental reference","author":"Physicians Desk Reference\/Micromedex","year":"2009"},{"key":"key\n\t\t\t\t20170522105241_CIS382C67","article-title":"Hepatitis C New Drug Research and Liver Health"},{"key":"key\n\t\t\t\t20170522105241_CIS382C68","article-title":"Merck's hepatitis C drug wins FDA approval","author":"Pollack"},{"key":"key\n\t\t\t\t20170522105241_CIS382C69","doi-asserted-by":"crossref","first-page":"E29","DOI":"10.1177\/0272989X10374508","article-title":"Predicting utility for joint health states: a general framework and a new nonparametric estimator","volume":"30","author":"Bo","year":"2010","journal-title":"Med Decis Making"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/55\/2\/279\/17350310\/cis382.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,22]],"date-time":"2024-04-22T20:26:14Z","timestamp":1713817574000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article-lookup\/doi\/10.1093\/cid\/cis382"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4,4]]},"references-count":69,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2012,4,4]]},"published-print":{"date-parts":[[2012,7,15]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/cis382","relation":{},"ISSN":["1537-6591","1058-4838"],"issn-type":[{"value":"1537-6591","type":"electronic"},{"value":"1058-4838","type":"print"}],"subject":[],"published":{"date-parts":[[2012,4,4]]}}}